![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 38, 26985-26991, September 17, 1999
,
§¶, and
§¶
From the Departments of
Neurology,
§ Cellular and Molecular Pharmacology, and the
¶ Neuroscience Graduate Program and Center for the Neurobiology of
Addiction, Ernest Gallo Clinic and Research Center, University of
California, San Francisco, California 94110-3518
| |
ABSTRACT |
|---|
|
|
|---|
Ethanol induces translocation of the catalytic
subunit (C The cAMP signaling pathway is a major target for ethanol in intact
cells (1). Receptor-stimulated increases in intracellular cAMP levels
cause dissociation of the catalytic subunit of
cAMP-dependent protein kinase
(PKA)1 from regulatory
subunits; the free catalytic subunit (C Brief exposure to ethanol increases basal (9, 10) and
receptor-stimulated cAMP production in neuronal cells in culture and
isolated brain preparations (9-13). In rat cerebellum, acute ethanol
exposure causes an increase in both phosphorylated CREB and
cAMP-responsive element binding activity (14). Chronic exposure to
ethanol results in an adaptive desensitization of cAMP production, in
cells in culture (9, 15-17), lymphocytes isolated from human alcoholics (18), and in mouse brains (19). There is also a decrease in
the phosphorylation of CREB in granule cells of rat cerebellum (20).
Decreased cAMP production may be because of a decrease in the amount
and/or activity of several key proteins in this pathway, including
Gs Recently, we have shown that one of the catalytic subunits of PKA,
C Materials--
All chemicals were purchased from Sigma except
where indicated.
Cell Culture--
NG108-15 neuroblastoma × glioma hybrid
cells obtained from the cell culture facility at the University of
California (San Francisco, CA) were grown in 10% Serum Plus (JRH
Biosciences, Lenexa, KS) in a 10% CO2 incubator at
37 °C, as described previously (17). The cells were seeded at a
density of 2 × 106 cells in T175 flasks for nuclear
extract preparations and into 6-well plates at a density of 6 × 104 cells/well for whole cell lysate preparations. For
immunocytochemistry experiments, cells were plated on single chamber
slides at a density of 4-6 × 104 cells/slide. All
cells were maintained for 3 days in complete defined medium (10). On
day 3, media were changed, and the cells were maintained in the absence
or presence of 200 mM ethanol for 24 h; media were
replaced daily. Treatment with 10 µM forskolin was
carried out for 30 min. 40 µM
(Rp)-cAMPS (Biolog Life Science Institute, La
Jolla, CA) and 10 µM BWA1434U (a gift from Glaxo Wellcome) were added 3 h or 30 min, respectively, prior to ethanol or forskolin exposure.
Immunocytochemistry--
Cells were fixed, blocked, and
incubated with primary and secondary antibodies as described elsewhere
(23). Antibody against CREB phosphorylated at Ser-133 was purchased
from NEN BioLabs (Beverly, MA) and diluted 1:200. Secondary antibody
(fluorescein isothiocyanate-conjugated goat anti-rabbit) was purchased
from Cappel (Costa Mesa, CA) and diluted 1:250.
Nuclear Extracts--
Nuclei were isolated from NG108-15 cells
in hypertonic sucrose by the procedure of Laks et al. (27).
The nuclear pellet was resuspended in extraction buffer (10 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 2 mM dithiothreitol, 0.5 M NaCl, 0.1 mM EDTA, protease inhibitors (0.1 mM
phenylmethylsulfonyl fluoride, 100 µg/ml aprotinin, 100 µg/ml
leupeptin), and phosphatase inhibitors (20 mM NaF, 1 mM sodium orthovanadate)) and shaken at 4 °C for 60 min.
After centrifugation for 20 min at 67,000 × g, protein
content and PKA activity were determined in the supernatant, and a
fraction was used for Western blot analysis.
PKA Assay--
Nuclear extracts (0.6 mg/ml protein) were
incubated in 50 mM phosphate buffer in the presence and
absence of 5 µM cAMP. The reaction was started by adding
10 µl of reaction mixture containing 10 mM magnesium
acetate, 200 µM ATP, 200 µM Kemptide, and
12.5 µCi/ml [ Gel Filtration Assay--
A Sephadex G-75 column (Amersham
Pharmacia Biotech) (15 × 250 mm) was preequilibrated with binding
buffer (50 mM potassium phosphate, pH 7.0, 4 mM
2-mercaptoethanol, and 75 mM NaCl) (28) and used to
separate PKA holoenzyme from dissociated C Immunoprecipitation--
Nuclear extract (0.5 mg of protein) was
prepared as described above (except that NaCl was omitted from
extraction buffer) and was precleared for 30 min with protein
A-conjugated agarose. Supernatant from a 10 min centrifugation at
10,000 rpm was incubated overnight with 2 µg of polyclonal C Western Blots--
Whole cell lysates were prepared by washing
cells with ice-cold phosphate-buffered saline and collecting them in
SDS buffer (100 µl/well from 4 wells) followed by sonication for
3 s. Cells from 2 remaining wells were used for protein
measurements. Nuclear extracts and cell lysates were subjected to
SDS-polyacrylamide gel electrophoresis (29), and proteins were
transferred to polyvinylidene difluoride membranes. Blots were probed
using standard procedures (30) and antibodies against C Ethanol Increases the Amount of C Nuclear PKA Activity Is cAMP-independent in Ethanol-treated
NG108-15 Cells--
Our data suggest that the amount of C Ethanol Inhibits Binding of C
To determine directly whether ethanol inhibits binding of RII to C
Our findings suggest that ethanol interferes with the reassociation of
RII and C Ethanol Inhibits Interaction of PKI with C Ethanol Inhibits Interaction of C Ethanol-induced Translocation of C Adenosine A2 Receptors Mediate Ethanol-induced CREB
Phosphorylation--
We have previously shown that adenosine
A2 receptors mediate acute ethanol-induced increases in
cAMP levels; adenosine A2 receptor blockade completely
prevents ethanol-induced cAMP accumulation (9, 10). If adenosine
receptor-dependent increases in cAMP levels are responsible
for ethanol-induced activation and translocation of C Immunocytochemical studies in our laboratory have shown that
chronic exposure of NG108-15 cells to ethanol caused a dramatic and
specific translocation of C Our data also suggest a mechanism for the prolonged sequestration of
functionally active C Two apparent methodological discrepancies in our studies are
informative. First, in our previous paper (23), ethanol caused the
translocation to the nucleus of almost all C Ethanol-induced translocation of C Several reports have shown that other kinases can phosphorylate CREB
in vitro and in vivo on Ser-133, e.g.
calmodulin-dependent kinase IV (32-35), mitogen-activated protein
kinase (36), and protein kinase C (37). In NG108-15 cells, the
increase in CREB phosphorylation during ethanol exposure appears to be
due primarily to C In summary, the major finding in this paper is that ethanol-induced
translocation of PKA C
) of cAMP-dependent protein kinase (PKA) from
the Golgi area to the nucleus in NG108-15 cells. Ethanol also induces
translocation of the RII
regulatory subunit of PKA to the nucleus;
RI and C
are not translocated. Nuclear PKA activity in
ethanol-treated cells is no longer regulated by cAMP. Gel filtration
and immunoprecipitation analysis confirm that ethanol blocks the
reassociation of C
with RII but does not induce dissociation of
these subunits. Ethanol also reduces inhibition of C
by the PKA
inhibitor PKI. Pre-incubation of C
with ethanol decreases
phosphorylation of Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide) and casein
but has no effect on the phosphorylation of highly charged molecules
such as histone H1 or protamine. cAMP-response element-binding protein
(CREB) phosphorylation by C
is also increased in ethanol-treated
cells. This increase in CREB phosphorylation is inhibited by the PKA
antagonist (Rp)-cAMPS and by an adenosine receptor antagonist. These results suggest that ethanol affects a
cascade of events allowing for sustained nuclear localization of C
and prolonged CREB phosphorylation. These events may account for
ethanol-induced changes in cAMP-dependent gene expression.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
) then phosphorylates
intracellular substrates. The duration of the stimulus determines
whether these substrates are cytoplasmic or nuclear (2). In the
nucleus, PKA C
phosphorylates a specific transcription factor, CREB,
at serine 133, initiating changes in expression of genes containing
cAMP response elements (3-5). Translocation of C
to the nucleus
following receptor activation is transient, and C
rapidly exits the
nucleus (6). Export of C
out of the nucleus is mediated by binding
of C
to the heat stable PKA inhibitor, PKI, which contains a nuclear
export signal (7, 8).
(21), Gq (22), PKA regulatory subunit RI
(23), and PKA catalytic activity (24, 25). Increases in Gi
have also been reported after chronic exposure to ethanol (26).
, translocates to the nucleus of NG108-15 cells during prolonged
exposure to ethanol; C
remains in the nucleus as long as ethanol is
present (23). This is in contrast to the rapid exit of C
from the
nucleus when adenylyl cyclase and PKA are activated by receptors or
forskolin (6). Because prolonged intranuclear localization of C
during exposure to ethanol could be responsible for ethanol-induced
changes in gene expression (see Ref. 1 for review), we undertook a
study to determine the mechanism and functional significance of
ethanol-induced C
translocation. We show here that ethanol-induced
nuclear C
is functionally active, resulting in the phosphorylation
of CREB. This persistent activation appears to be because of, in part, ethanol inhibition of C
reassociation with regulatory subunits of
PKA and ethanol-dependent inactivation of PKI.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP, specific activity 3000 Ci/mmol (Amersham Pharmacia Biotech). The reaction was stopped after
incubation for 5 min at 37 °C, and the amount of
-32P
incorporated into Kemptide was determined as described by Rabin et al. (11). The PKA catalytic subunit (Sigma) was
reconstituted in 40 mM dithiothreitol to a final
concentration of 0.05 mg/ml and was used within 3 days. For each
experiment, enzyme was diluted 50-fold in assay buffer with or without
various concentrations of ethanol. The final concentration of enzyme
was 0.51 units/0.13 mM histone H1 (Life Technologies, Inc.)
and 0.2 mM Kemptide, casein, or protamine sulfate.
and RII subunits. The
void volume was determined to be 14 ml. At a flow rate of 1 ml/min,
holoenzyme elutes in the void volume (RII at 36 ml and C
at 40 ml).
Kinase activity was measured in these fractions as described above,
using 10 mg/ml protamine sulfate as substrate, because ethanol has no
effect on phosphorylation of this substrate (see Fig. 4B).
Phosphorylation in the void volume containing holoenzyme is
cAMP-dependent, whereas kinase activity in the 40-ml
fraction containing C
is cAMP-independent.
antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA) and further
incubated with protein A-conjugated agarose for 1 h. The
immunoprecipitate was centrifuged and washed four times with
phosphate-buffered saline, pH 7.0. All incubations were at 4 °C.
After a final wash, the immunoprecipitate was resuspended in SDS sample
buffer, subjected to SDS-polyacrylamide gel electrophoresis, and probed
with RII
(Transduction Laboratories, Lexington, KY) and C
antibodies on Western blots.
(a generous
gift from Susan Taylor, University of California, San Diego, CA)
(diluted 1:10,000), RI, RII
, and RII
(Transduction Laboratories)
(1:1000), C
(Santa Cruz Biotechnology Inc.) (1:1000), or total CREB
and phosphorylated CREB (NEN BioLabs) (1:1000). Secondary antibodies
(NEN BioLabs) were horseradish peroxidase-linked goat anti-rabbit
(1:5000) for C
, C
, CREB, and phospho-CREB and rabbit anti-mouse
(1:1000) for RI and RII. Proteins were detected using LumiGLO
chemiluminescence substrate (NEN BioLabs) and exposed to Kodak Biomax
film. Scanning densitometry was used to quantitate Western blots using
the NIH Image program.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
and RII
in the Nucleus of
NG108-15 Cells--
Using immunocytochemistry, we have shown that
chronic ethanol exposure causes translocation of PKA C
from the
Golgi area into the nucleus in NG108-15 cells (23). To quantitate the
extent of C
translocation and to determine whether ethanol causes
translocation to the nucleus of other PKA subunits in NG108-15 cells,
we carried out Western blots on cell lysates and nuclei from these
cells. Fig. 1 shows that NG108-15 cells
express C
, C
, RI, and RII
. Only traces of RII
could be
detected in the presence or absence of ethanol (data not shown). After
incubation with ethanol for 24 h, there is a 54 ± 2%
(mean ± S.E.) increase in the amount of C
in the nuclei of
ethanol-treated cells and a 40 ± 5% decrease in the amount of RI
in whole cell homogenates. These results are in agreement with our
previous findings (23) that ethanol causes translocation of C
into
the nucleus and decreases the amount of RI subunit in whole cells. Fig.
1 also shows that, after exposure to ethanol, nuclear RII
increases
by 52 ± 4%. However, there is no RI or C
in the nuclei of
either control or ethanol-treated cells.

View larger version (39K):
[in a new window]
Fig. 1.
Immunodetection of PKA subunits in NG108-15
cells. Western blot of whole cells and nuclei from NG108-15 cells
cultured in the presence (+) or absence (
) of 200 mM
ethanol for 24 h. Each lane contained 40 or 80 µg of protein.
Molecular masses of the PKA subunits are 40 kDa for C
and C
, 54 kDa for RII
, and 48 kDa for RI. Data shown are representative of
five independent experiments.
and
RII
in the nucleus of NG108-15 cells increases by 50% after
chronic exposure to ethanol. To determine whether nuclear C
is
active or bound to RII
and thus inactive, we measured PKA activity
in the presence and absence of cAMP in nuclear extracts. Nuclei were
recovered after cell disruption and centrifugation in hypertonic
sucrose buffer, and soluble proteins were extracted with 0.5 M NaCl buffer (27). PKA activity in the extract was assayed
with Kemptide as substrate (11). Fig. 2
shows that PKA activity remaining in control nuclei after subcellular
fractionation is cAMP-dependent, suggesting that C
and
RII
are associated as a holoenzyme. In contrast, kinase activity in
the nuclei of cells treated with 200 mM ethanol for 24 h is cAMP-independent, suggesting that some of the C
is no longer
associated with RII
. Because total PKA activity did not change in
ethanol-treated cells, it is also likely that a significant fraction of
nuclear PKA is inactive after ethanol exposure.

View larger version (17K):
[in a new window]
Fig. 2.
C
activity is
independent of cAMP in nuclei of NG108-15 cells exposed to
ethanol. PKA activity in the nuclear extracts of control and
chronic (24 h) ethanol-treated NG108-15 cells in the presence
(solid bars) or absence (open bars) of cAMP using
Kemptide as substrate. Data shown are the mean ± S.E. for three
experiments. *, significantly different (p < 0.03)
from the corresponding control cells without cAMP. **, not
statistically different from chronically exposed cells minus cAMP
(Student's t test)
to RII--
The results in Fig. 2
suggest that active C
is not regulated by RII in the presence of
ethanol. To test this possibility, we examined RII inhibition of
purified C
activity in the presence or absence of ethanol. Fig.
3A shows that RII inhibits
C
catalytic activity by 72 ± 2% in the absence of ethanol.
However, preincubation of RII with ethanol strikingly decreases RII
inhibition of C
. When RII was preincubated with 50 mM
ethanol for 2 h, inhibition of C
activity by RII was reduced to
25 ± 1%. These results suggest that ethanol inhibits the binding
of RII to C
, thereby preventing RII inhibition of C
activity.

View larger version (32K):
[in a new window]
Fig. 3.
Ethanol prevents RII reassociation and
inhibition of C
but does not cause
dissociation of these subunits from the holoenzyme.
A, inhibition of C
activity by RII at various
concentrations of ethanol. Regulatory subunits (0.075 ng/µl) were
preincubated with 0 (
), 25 (
), 50 (
), or 100 mM
(
) ethanol for the indicated times, and inhibition of Kemptide
phosphorylation by C
(0.1 ng/µl) was measured as described under
"Experimental Procedures." The concentrations of RII and C
were
adjusted to equal units of activity. Data are the mean ± S.E. of
three experiments. B, effect of cAMP and ethanol on
association of C
and RII. Equimolar amounts of C
and RII (0.3 µM in 200 µl of binding buffer) were incubated for 30 min at room temperature with or without 100 µM cAMP or 50 mM ethanol (RII was preincubated for 60 min with ethanol).
The sample applied to a Sephadex G-75 column was eluted with binding
buffer containing the indicated additions. PKA activity was assayed in
the presence (filled bars) or absence (open bars)
of 100 µM cAMP. Results are shown as percent of total
activity applied to the column. Data are the mean ± S.E. of three
experiments. C, effect of cAMP and ethanol on dissociation
of the holoenzyme. Holoenzyme (0.3 µM in 200 µl of
buffer) was incubated for 30 min in the presence or absence of 100 µM cAMP or 200 mM ethanol, applied to the
column, and eluted with buffer containing the indicated additions.
Kinase activity was assayed in the presence (filled bars) or
absence (open bars) of 100 µM cAMP and is
presented as the percent of total activity applied to the column. Data
are the mean ± S.E. of three experiments. D,
co-immunoprecipitation of RII
with C
in nuclei of NG108-15 cells
cultured for 24 h in the presence (+) and absence (
) of 200 mM ethanol. The upper panel shows a
representative Western blot of the immunoprecipitate probed with the
indicated antibodies. The 55-kDa heavy chain of the polyclonal antibody
against C
is shown as IgG. The lower panel shows
densitometric quantitation of the immunoprecipitated C
(open
bars) and of the co-immunoprecipitated RII
(filled
bars). Data are the mean ± S.E. of four experiments. *,
significantly different (p < 0.02) from the
corresponding control cells.
,
association of the two subunits was assessed by Sephadex G-75 gel
filtration chromatography. The holoenzyme elutes in fraction 14 (void
volume) and C
in fraction 40. Fig. 3B shows that when equimolar amounts of C
and RII are co-incubated for 30 min without cAMP, all kinase activity is cAMP-dependent and is
recovered in the void volume (fraction 14). This indicates that RII and
C
associate to form the holoenzyme. When cAMP is present during both
incubation and elution, all PKA activity is recovered in fraction 40 and is cAMP-independent. This indicates that cAMP prevents the
association of C
and RII. When RII is preincubated with 50 mM ethanol for 60 min before incubation with C
and the column eluted with buffer containing 50 mM ethanol, only
46 ± 2% of PKA activity is in the void volume and 44 ± 4%
elutes in fraction 40, suggesting that ethanol inhibits the association of RII and C
by 54%. This is in agreement with the results in Fig.
3A showing a 45 ± 6% decrease in RII inhibition of
C
activity after RII was preincubated with 50 mM ethanol
for 90 min. Although ethanol inhibits the reassociation of PKA
subunits, it has no effect on the dissociation of the holoenzyme.
Incubation of holoenzyme with as much as 200 mM ethanol for
30 min did not cause dissociation into subunits, in contrast to
dissociation produced by cAMP (Fig. 3C).
subunits of PKA in vitro. To determine if ethanol produces the same effect in vivo, we performed
co-immunoprecipitation assays in nuclear extracts from NG108-15 cells
maintained in the presence and absence of 200 mM ethanol
for 24 h. The C
·RII
complex was immunoprecipitated with a
polyclonal C
antibody and analyzed by Western blot using antibodies
against RII
and C
. Fig. 3D shows that the amount of
RII
co-immunoprecipitated with C
is 45 ± 2% less in the
nuclei of ethanol-treated cells. This is in agreement with the results
in Fig. 3, A and B, and suggests that C
and
RII
are partially dissociated in the nuclei of these cells.
--
We have shown
that C
remains in the nuclei of ethanol-treated NG108-15 cells as
long as ethanol is present and returns to the Golgi 12 h after
ethanol is removed (23). C
ordinarily exits the nucleus by binding
to the heat-stable PKA inhibitor, PKI, which contains a nuclear export
signal required for transporting proteins out of the nucleus (7, 8).
Because PKI binds to the same hydrophobic site on C
as RII
(31),
it is possible that ethanol also inhibits the binding of PKI to C
.
This would be expected to attenuate inhibition of C
by PKI and limit
the export of C
from the nucleus. We used an in vitro
kinase assay to test this hypothesis. Under control conditions PKI
inhibits purified C
-catalyzed phosphorylation by 84 ± 6%
(Fig. 4A). Preincubation of
PKI with 50 or 100 mM ethanol for 30 min at room
temperature decreases PKI inhibition of kinase activity to 31 ± 5% and 14 ± 6%, respectively. Thus, ethanol limits inhibition
of PKA by PKI, suggesting that ethanol, similar to its effect on RII,
probably inhibits the binding of PKI to C
. This would also prevent
the exit of C
from the nucleus.

View larger version (21K):
[in a new window]
Fig. 4.
Ethanol prevents PKI inhibition of
C
activity and differentially affects
phosphorylation of substrates. A, ethanol abolishes
inhibition of C
by PKI. PKI was preincubated in the presence of 50 or 100 mM ethanol for 30 min at room temperature and then
added to the reaction mixture (final PKI concentration, 187 ng/µl).
Phosphorylation of Kemptide by C
at 37 °C was measured at 5 min.
Data are the mean ± S.E. of three experiments. *, significantly
different (p < 0.01) from the value obtained in the
absence of ethanol (Student's t test). B,
ethanol preferentially inhibits phosphorylation of specific substrates
by C
. The catalytic subunit of PKA was preincubated with 50 (open bars) or 100 (hatched bars) mM
ethanol for 30 min, and phosphorylation of Kemptide (Kemp),
casein (Cas), histone (H1), and protamine sulfate
(Prot) was measured. Data are the mean ± S.E. of three
experiments.
with Substrates--
Because
PKI and RII share common binding sites on C
with substrates (31), we
determined the effect of ethanol on C
-mediated phosphorylation of
different substrates in vitro. Fig. 4B shows that
C
preincubation with 100 mM ethanol for 30 min inhibits C
-dependent phosphorylation of Kemptide or casein by
36%. However, 100 mM ethanol did not inhibit
phosphorylation of the highly charged molecules histone H1 or protamine
sulfate. Similar results were obtained with 50 mM ethanol.
Moreover, preincubation of all substrates with 100 mM
ethanol did not affect subsequent phosphorylation, except for casein
where inhibition of phosphorylation was reduced from 36 to 25% (data
not shown). These results suggest that ethanol inhibits phosphorylation
of hydrophobic substrates by interacting primarily with hydrophobic
sites on C
.
Leads to Phosphorylation of
CREB--
C
localized to the nucleus after exposure to ethanol is
active (Fig. 2), suggesting that endogenous nuclear substrates should also be phosphorylated. The transcription factor CREB is a
physiological substrate for PKA in the nucleus (3-5). Therefore, we
used Western blot analysis and immunocytochemistry with polyclonal
antibodies that recognize CREB phosphorylated at serine 133 (phospho-CREB) to determine whether ethanol increases CREB
phosphorylation. Fig. 5, A and
B, shows that ethanol induces phosphorylation of CREB (p-CREB) reaching a maximum at 3 h of exposure. Most
importantly phospho-CREB remains higher than control levels from 1-24
h of ethanol treatment; there was no change in the amount of CREB (Fig. 5A). Because CREB can be phosphorylated at serine 133 by
several other kinases (32-37), we used the PKA antagonist
(Rp)-cAMPS to confirm that the ethanol-induced
increase in phospho-CREB was due primarily to PKA. Fig.
6 shows an immunocytochemical image of
phospho-CREB in NG108-15 cells before and after treatment with either
forskolin or ethanol. The amount of phospho-CREB in the nucleus after a
3-h exposure to ethanol is similar to that obtained by treating the
cells with forskolin for 30 min (Fig. 6). Forskolin- and
ethanol-induced phosphorylation of CREB was greatly reduced by
preincubating cells with (Rp)-cAMPS, suggesting
that PKA is responsible for CREB phosphorylation induced by
ethanol.

View larger version (27K):
[in a new window]
Fig. 5.
CREB phosphorylation induced by ethanol in
NG108-15 cells. A, phosphorylated CREB and total CREB
protein in homogenates of NG108-15 cells as a function of time of
ethanol exposure. Western blot of NG108-15 cells cultured in the
presence or absence of 200 mM ethanol for the indicated
times. C represents control cells incubated for 24 h in
the absence of ethanol, and F represents cells treated with
10 µM forskolin for 30 min. Data shown are representative
of four experiments. B, densitometric quantitation of
phosphorylation of CREB in NG108-15 cells treated with ethanol. Data
are the means of four experiments. *, significantly different
(p < 0.05) from the corresponding control cells
without ethanol (Student's t test).

View larger version (41K):
[in a new window]
Fig. 6.
Ethanol-induced CREB phosphorylation in
NG108-15 cells is blocked by adenosine receptor and PKA
antagonists. Immunocytochemical detection of phospho-CREB in
NG108-15 cells treated with ethanol for 3 h. Positive control:
cells treated for 30 min with 10 µM forskolin.
Pretreatment with (Rp)-cAMPS and BWA1434U was as
described under "Experimental Procedures." All images are ×400
magnification obtained with a Bio-Rad 1024 confocal microscope. Data
shown are representative of three experiments.
to the
nucleus, an adenosine receptor antagonist should also block
phosphorylation of CREB. BWA1434U, an adenosine receptor antagonist,
blocked ethanol-induced CREB phosphorylation but, as expected, had no
effect on forskolin-induced CREB phosphorylation, which bypasses
receptor stimulation (Fig. 6).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
from the Golgi area to the nucleus (23).
This translocation is confirmed by Western blot analysis of homogenates
and nuclei of control and ethanol-treated cells (Fig. 1). We
demonstrate here that the RII
regulatory subunit is also
translocated to the nucleus following chronic ethanol exposure, but
ethanol does not alter localization of the C
catalytic subunit.
Nuclei of control NG108-15 cells contain both C
and RII
,
probably associated as holoenzyme, because cAMP is required for PKA
activation (Fig. 2). After chronic ethanol exposure, however, there is
a substantial increase in the amounts of both C
and RII
in the
nucleus (Fig. 1). Once in the nuclei of ethanol-treated cells, some
C
and RII
appear to be dissociated because PKA activity is
cAMP-independent (Fig. 2). This is likely because of the inhibition of
the association of C
and RII by ethanol (Fig. 3B) thereby blocking RII regulation of C
activity (Fig. 3A). Thus, a
90-min incubation with 50 mM ethanol prevents the
association of RII and C
by 50% (Fig. 3B) and decreases
RII inhibition of C
activity by 45% (Fig. 3A). This
concentration of ethanol is clinically relevant, particularly in
chronic alcoholics (38). Moreover, ethanol inhibition of C
·RII
holoenzyme formation in vitro is reproduced in
vivo because 45% of nuclear RII
fails to co-immunoprecipitate with C
after 24 h of ethanol treatment (Fig.
3D).
in the nucleus in the presence of ethanol.
Neurotransmitter- and hormone-dependent signal transduction via cAMP cause a transient translocation of PKA C
from the cytoplasm to the nucleus with brief activation of transcription; C
returns rapidly to the cytoplasm after binding to PKI (6-8). During prolonged exposure to ethanol, however, C
remains in the nucleus and returns to the Golgi only 6-12 h after ethanol is removed (23). This unusual
time course for C
translocation could be because of the interaction
of ethanol with hydrophobic binding sites on PKI that prevents PKI from
binding to C
, thereby inhibiting PKI-mediated export of C
out of
the nucleus. Indeed, the data presented here show that PKI inhibition
of C
activity is greatly reduced after preincubation with ethanol
(Fig. 4A). Presumably this is because ethanol prevents the
binding of PKI to C
, similar to ethanol interfering with the
association of RII
with C
(Fig. 3, B and D). Ethanol also appears to limit access of specific
substrates to C
; phosphorylation of Kemptide and casein by C
is
reduced after preincubation of C
with ethanol, whereas
phosphorylation of histone and protamine are unaffected by ethanol
(Fig. 4B). The binding of substrates and RII and PKI to the
catalytic subunit of PKA involves two hydrophobic interactions and
three electrostatic contacts (31). Recent evidence suggests that
ethanol can bind directly to hydrophobic pockets in proteins (39-41).
Therefore, we propose that ethanol-induced sustained translocation of
C
to the nucleus is related to ethanol inhibition of the
reassociation of C
with RII and/or the binding of C
to PKI. This
may be because of ethanol-induced conformational changes at hydrophobic
sites near the binding domains. This explanation is also consistent with our observation that ethanol does not inhibit phosphorylation of
substrates that are highly charged, such as histone H1 and protamine
sulfate (Fig. 4B), where hydrophilic binding to C
probably predominates. Preincubation of substrates with ethanol does
not produce the same decrease in Kemptide and casein phosphorylation as
preincubation of C
. We presume this occurs because Kemptide and
casein have a random coil secondary structure (42, 43) that is less
affected by ethanol.
observable by confocal
microscopy. In this report, Western blot analysis indicates that only
approximately 50% of C
is translocated to the nucleus. This
discrepancy can be explained by methodological differences; we used
confocal microscopy in our earlier report and Western blot analysis in
this study. Confocal microscopy results in visualization of densely
localized C
, as seen in the Golgi and nuclei. Diffusely distributed
C
, on the other hand, is more difficult to observe by microscopy but
is readily detected by Western blot analysis. The second discrepancy is
that Western blot analysis shows a 50% increase in C
in the nucleus
after exposure to ethanol; this is not accompanied by an increase in
PKA enzymatic activity, suggesting that some nuclear C
may be
rendered inactive and no longer regulated by cAMP after chronic
exposure to ethanol. This raises the very interesting possibility that
some C
may be retained in the nucleus after chronic exposure to
ethanol by binding to a putative inactivating protein distinct from PKI
and RII. The existence of such a hypothetical C
-binding protein in
the nucleus is suggested by our observation that sustained nuclear
localization of C
in the presence of ethanol requires protein
synthesis.2 Studies are
underway to identify this putative binding protein.
to the nucleus should enhance
cAMP-dependent gene expression and reduce phosphorylation of membrane or cytoplasmic proteins. Because C
is active for long
periods of time, there may even be inappropriate transcription of
cAMP-responsive genes. This is suggested by our finding that ethanol
causes a striking increase in CREB phosphorylation with a peak at
3 h, followed by a sustained increase in phospho-CREB even after
24 h of ethanol exposure (Fig. 5). The peak of CREB phosphorylation at 3 h appears to be because of unrestrained C
activity, apparently because ethanol inhibits RII and PKI binding to
C
(Figs. 3 and 4A). After 3 h, phospho-CREB remains
higher than in control cells but decreases despite the continued
presence of C
in the nucleus (see Ref. 18 and Fig. 4). This may be
related to the observation that CREB phosphorylation following
activation of the cAMP pathway is also regulated by protein
phosphatases such as protein phosphatase 2B in neurons of the striatum
(44) and protein phosphatase 1 in PC12 cells (45). Therefore, the decrease in CREB phosphorylation after 3 h may be because of an ethanol-induced increase in nuclear protein phosphatase activity.
, because the PKA-specific inhibitor
(Rp)-cAMPS, which acts directly on the
holoenzyme to prevent its dissociation, significantly but not
completely inhibits phosphorylation of CREB (Fig. 6). This suggests the
possibility that an early activation of PKA by ethanol-induced
increases in cAMP may also up-regulate other kinases that phosphorylate
CREB. However, an ethanol-induced increase in cAMP production must be
required for CREB phosphorylation in the nucleus because BWA1434U, an
adenosine receptor antagonist that blocks acute ethanol-induced
increases in cAMP levels (9, 10), completely abolishes ethanol-induced
phosphorylation of CREB (Fig. 6). This is consistent with recent data
in our laboratory showing that both (Rp)-cAMPS
and BWA1434U prevent acute ethanol-induced translocation of C
into
the nucleus.2 Moreover, a requirement for cAMP is also
supported by data in Fig. 3C showing that ethanol alone does
not dissociate the PKA holoenzyme.
to the nucleus in NG108-15 cells causes a
sustained increase in CREB phosphorylation. CREB phosphorylation has
long been implicated in the regulation of many cellular functions and
in short and long term learning and memory (46-48). Taken together with recent genetic data implicating cAMP signaling in alcohol-related behaviors (49, 50), ethanol regulation of cAMP-dependent
gene transcription may play an important role in molecular mechanisms that underlie alcoholism and addictive behaviors.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Michael Miles and Dorit Ron for helpful discussion and critical review of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Grants R01 AA10039 and R01 AA10030.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Bldg. 1, Rm. 101, Ernest Gallo Clinic and Research Center, 1001 Potrero Ave., San
Francisco, CA 94110-3518. Tel.: (415) 648-7111 (ext. 305); Fax: (415)
648-7116; E-mail: adrienn@itsa.ucsf.edu.
2 D. Dohrman, H.-m., Chen, I. Diamond, and A. Gordon, manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PKA, cAMP-dependent protein kinase; CREB, cAMP-response element-binding protein; PKI, protein kinase inhibitor, cAMPS, adenosine 3',5' cyclic monophosphorothioate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Diamond, I.,
and Gordon, A. S.
(1997)
Physiol. Rev.
77,
1-20 |
| 2. |
Bailey, C. H.,
Bartsch, D.,
and Kandel, E. R.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13445-13452 |
| 3. | Bailey, C. H., Alberini, C., Ghirardi, M., and Kandel, E. R. (1994) Adv. Second Messenger Phosphoprotein Res. 29, 529-544[Medline] [Order article via Infotrieve] |
| 4. |
Brindle, P.,
Nakajima, T.,
and Montminy, M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10521-10525 |
| 5. |
Hagiwara, M.,
Brindle, P.,
Harootunian, A.,
Armstrong, R.,
Rivier, J.,
Vale, W.,
Tsien, R.,
and Montminy, M. R.
(1993)
Mol. Cell. Biol.
13,
4852-4859 |
| 6. | Nigg, E. A., Hilz, H., Eppenberger, H. M., and Dutly, F. (1985) EMBO J. 4, 2801-2806[Medline] [Order article via Infotrieve] |
| 7. | Meinkoth, J. L., Alberts, A. S., Went, W., Fantozzi, D., Taylor, S. S., Hagiwara, M., Montminy, M., and Feramisco, J. R. (1993) Mol. Cell. Biochem. 127, 179-186 |
| 8. |
Fantozzi, D. A.,
Harootunian, A. T.,
Wen, W.,
Taylor, S. S.,
Feramisco, J. R.,
Tsien, R. Y.,
and Meinkoth, J. L.
(1994)
J. Biol. Chem.
269,
2676-2686 |
| 9. | Nagy, L. E., Diamond, I., Collier, K., Lopez, L., Ullman, B., and Gordon, A. S. (1989) Mol. Pharmacol. 36, 744-748[Abstract] |
| 10. |
Sapru, M. K.,
Diamond, I.,
and Gordon, A. S.
(1994)
J. Pharmacol. Exp. Ther.
271,
542-548 |
| 11. |
Rabin, R. A.,
Edelman, A. M.,
and Wagner, J. A.
(1992)
J. Pharmacol. Exp. Ther.
262,
257-262 |
| 12. | Tabakoff, B., Hoffman, P. L., Lee, J. M., Saito, T., Willard, B., and De Leon-Jones, F. (1988) N. Engl. J. Med. 318, 134-139[Abstract] |
| 13. | Saito, T., Lee, J. M., and Tabakoff, B. (1985) J. Neurochem. 44, 1037-1044[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Yang, X.,
Diehl, A. M.,
and Wand, G. S.
(1996)
J. Pharmacol. Exp. Ther.
278,
338-346 |
| 15. | Rabe, C. S., Giri, P. R., Hoffman, P. L., and Tabakoff, B. (1990) Biochem. Pharmacol. 40, 565-571[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Rabin, R. A., Fiorella, D., and Van Wylen, D. G. (1993) J. Neurochem. 60, 1012-1017[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Gordon, A. S.,
Collier, K.,
and Diamond, I.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
2105-2108 |
| 18. |
Diamond, I.,
Wrubel, B.,
Estrin, W.,
and Gordon, A.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
1413-1416 |
| 19. |
Wand, G. S.,
Diehl, A. M.,
Levine, M. A.,
Wolfgang, D.,
and Samy, S.
(1993)
J. Biol. Chem.
268,
2595-2601 |
| 20. | Yang, X., Horn, K., Baraban, J. M., and Wand, G. S. (1998) J. Neurochem. 70, 224-232[Medline] [Order article via Infotrieve] |
| 21. | Mochly-Rosen, D., Chang, F. H., Cheever, L., Kim, M., Diamond, I., and Gordon, A. S. (1988) Nature 333, 848-850[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Williams, R. J., and Kelly, E. (1993) J. Neurochem. 61, 1163-1166[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Dohrman, D. P.,
Diamond, I.,
and Gordon, A. S.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10217-10221 |
| 24. |
Coe, I. R.,
Dohrman, D. P.,
Constantinescu, A.,
Diamond, I.,
and Gordon, A. S.
(1996)
J. Pharmacol. Exp. Ther.
276,
365-369 |
| 25. | Rius, R. A., Govoni, S., Battaini, F., and Trabucchi, M. (1986) Brain Res. 365, 355-359[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Charness, M. E., Querimit, L. A., and Henteleff, M. (1988) Biochem. Biophys. Res. Commun. 155, 138-143[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Laks, M. S.,
Harrison, J. J.,
Schwoch, G.,
and Jungmann, R. A.
(1981)
J. Biol. Chem.
256,
8775-8785 |
| 28. |
Rangel-Aldao, R.,
and Rosen, O. M.
(1976)
J. Biol. Chem.
251,
3375-3380 |
| 29. | Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Towbin, H.,
Staehelin, T.,
and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354 |
| 31. | Kemp, B. E., Faux, M. C., Means, A. R., House, C., Tiganis, T., Hu, S.-H., and Mitchelhill, K. I. (1994) in Protein Kinases (Woodgett, J. R., ed) , pp. 30-67, IRL Press at Oxford University Press, New York |
| 32. | Hanson, P. I., and Schulman, H. (1992) Annu. Rev. Biochem. 61, 559-601[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Greenberg, M. E., Thompson, M. A., and Sheng, M. (1992) J. Physiol. (Paris) 86, 99-108[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Sun, P.,
Lou, L.,
and Maurer, R. A.
(1996)
J. Biol. Chem.
271,
3066-3073 |
| 35. | Bito, H., Deisseroth, K., and Tsien, R. W. (1996) Cell 87, 1203-1214[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Bailey, C. H., Kaang, B. K., Chen, M., Martin, K. C., Lim, C. S., Casadio, A., and Kandel, E. R. (1997) Neuron 18, 913-924[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Xie, H., and Rothstein, T. L. (1995) J. Immunol. 154, 1717-1723[Abstract] |
| 38. | Diamond, I., and Messing, R. O. (1994) West. J. Med. 161, 279-287[Medline] [Order article via Infotrieve] |
| 39. | Slater, S. J., Cox, K. J., Lombardi, J. V., Ho, C., Kelly, M. B., Rubin, E., and Stubbs, C. D. (1993) Nature 364, 82-84[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Li, C.,
Peoples, R. W.,
and Weight, F. F.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8200-8204 |
| 41. | Eckenhoff, R. G., and Shuman, H. (1993) Anesthesiology 79, 96-106[Medline] [Order article via Infotrieve] |
| 42. | Rosevear, P. R., Fry, D. C., Mildvan, A. S., Doughty, M., O'Brian, C., and Kaiser, E. T. (1984) Biochemistry 23, 3161-3173[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | de Jongh, H. H., Goormaghtigh, E., and Ruysschaert, J. M. (1997) Biochemistry 36, 13603-13610[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Liu, F. C., and Graybiel, A. M. (1996) Neuron 17, 1133-1144[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Hagiwara, M., Alberts, A., Brindle, P., Meinkoth, J., Feramisco, J., Deng, T., Karin, M., Shenolikar, S., and Montminy, M. (1992) Cell 70, 105-113[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Martin, K. C., Casadio, A., Zhu, H., E. Y., Rose, J. C., Chen, M., Bailey, C. H., and Kandel, E. R. (1997) Cell 91, 927-938[CrossRef][Medline] [Order article via Infotrieve] |
| 47. | Bartsch, D., Ghirardi, M., Skehel, P. A., Karl, K. A., Herder, S. P., Chen, M., Bailey, C. H., and Kandel, E. R. (1995) Cell 83, 979-992[CrossRef][Medline] [Order article via Infotrieve] |
| 48. | Kaang, B. K., Kandel, E. R., and Grant, S. G. (1993) Neuron 10, 427-435[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | Moore, M. S., DeZazzo, J., Luk, A. Y., Tully, T., Singh, C. M., and Heberlein, U. (1998) Cell 93, 997-1007[CrossRef][Medline] [Order article via Infotrieve] |
| 50. | Thiele, T. E., Marsh, D. J., Ste, Marie, L., Bernstein, I. L., and Palmiter, R. D. (1998) Nature 396, 366-369[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
E. Meoli, I. Bossis, L. Cazabat, M. Mavrakis, A. Horvath, S. Stergiopoulos, M. L. Shiferaw, G. Fumey, K. Perlemoine, M. Muchow, et al. Protein Kinase A Effects of an Expressed PRKAR1A Mutation Associated with Aggressive Tumors Cancer Res., May 1, 2008; 68(9): 3133 - 3141. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ron and R. Jurd The "Ups and Downs" of Signaling Cascades in Addiction Sci. Signal., November 8, 2005; 2005(309): re14 - re14. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Goodlett, K. H. Horn, and F. C. Zhou Alcohol Teratogenesis: Mechanisms of Damage and Strategies for Intervention Experimental Biology and Medicine, June 1, 2005; 230(6): 394 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Maas Jr, S. K. Vogt, G. C. K. Chan, V. V. Pineda, D. R. Storm, and L. J. Muglia Calcium-Stimulated Adenylyl Cyclases Are Critical Modulators of Neuronal Ethanol Sensitivity J. Neurosci., April 20, 2005; 25(16): 4118 - 4126. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Medina, T. E. Krahe, and A. S. Ramoa Early Alcohol Exposure Induces Persistent Alteration of Cortical Columnar Organization and Reduced Orientation Selectivity in the Visual Cortex J Neurophysiol, March 1, 2005; 93(3): 1317 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Constantinescu, M. Wu, O. Asher, and I. Diamond cAMP-dependent Protein Kinase Type I Regulates Ethanol-induced cAMP Response Element-mediated Gene Expression via Activation of CREB-binding Protein and Inhibition of MAPK J. Biol. Chem., October 8, 2004; 279(41): 43321 - 43329. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Elliott, R. A. Shanks, I. U. Khan, J. W. Brooks, P. J. Burkett, B. J. Nelson, V. Kyttaris, Y.-T. Juang, G. C. Tsokos, and G. M. Kammer Down-Regulation of IL-2 Production in T Lymphocytes by Phosphorylated Protein Kinase A-RII{beta} J. Immunol., June 15, 2004; 172(12): 7804 - 7812. [Abstract] [Full Text] [PDF] |
||||